Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures - Scorecard - MDSpire

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures

  • By

  • Zhuqin Xiang

  • Yaqi Huang

  • Bokai Yun

  • Dongpeng Li

  • Fengshuo Liu

  • Junliang Liu

  • Nan Xie

  • Zehang Zhuang

  • Jinsong Hou

  • Cheng Wang

  • June 3, 2026

  • 0 min

Share

Clinical Scorecard: Assessing Prognostic Factors in Oral Squamous Cell Carcinoma Through Combined Analysis of Tumor Budding and Tertiary Lymphoid Structures

At a Glance

CategoryDetail
ConditionOral Squamous Cell Carcinoma (OSCC)
Key MechanismsTumor Budding (TB) and Tertiary Lymphoid Structures (TLS)
Target PopulationPatients diagnosed with OSCC
Care SettingRetrospective study in a clinical setting

Key Highlights

  • High-grade TB correlates with poor survival outcomes.
  • High-maturation TLS indicates favorable survival outcomes.
  • The TB/TLS index shows superior prognostic ability compared to single biomarkers.
  • A nomogram incorporating the TB/TLS index was developed and validated.
  • External validation demonstrated moderate predictive performance of the nomogram.

Guideline-Based Recommendations

Diagnosis

  • Histopathological confirmation of OSCC is required.

Management

  • Surgical resection is the mainstay of treatment, supplemented by radiotherapy and chemotherapy.

Monitoring & Follow-up

  • Utilize the TB/TLS index for prognostic assessment.

Risks

  • High-grade TB is associated with increased risk of poor survival.

Patient & Prescribing Data

510 patients diagnosed with OSCC in the study.

The study emphasizes the need for integrated prognostic models to guide treatment strategies.

Clinical Best Practices

  • Incorporate TB and TLS analysis in prognostic evaluations.
  • Utilize nomogram models for individualized patient prognosis.

Related Resources & Content

Original Source(s)

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures

  • by Zhuqin Xiang, Yaqi Huang, Bokai Yun, Dongpeng Li, Fengshuo Liu, Junliang Liu, Nan Xie, Zehang Zhuang, Jinsong Hou, Cheng Wang

  • June 3, 2026

Related Content

Association between EAT-Lancet diet adherence and cancer incidence/mortality: a systematic review and meta-analysis

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

Effectiveness of a culturally adapted psychoeducational intervention for family caregivers of children with hematologic malignancy: a randomized controlled trial